×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Vifor Pharma offers to fix alleged anti-competitive behaviour
Reuters
Vifor Pharma has offered to launch a marketing campaign to address any damage caused by its criticisms of a rival to its key drug,...
1 month ago
After Vifor buyout, CSL CEO sees 'dampened' outlook for the unit as hurdles mount
Fierce Pharma
Even as Australia's CSL continues to grow, the company's ambitions for its kidney disease and iron deficiency outfit Vifor Pharma—now known...
3 months ago
Disparagement Alleged in Iron Medicine Market: EU Commission Seeks Public Feedback on Company's Proposed ...
Morgan Lewis
The European Commission on April 19 opened a public consultation on commitments proposed by Vifor Pharma in response to a formal...
1 month ago
Vifor Pharma shares jump 15% as takeover talks with CSL confirmed
Yahoo Movies UK
ZURICH/SYDNEY (Reuters) -Vifor Pharma's shares surged more than 15% in early trading on Monday after the Swiss drugmaker and Australia's CSL...
5 days ago
EU and UK Consider First Stand-Alone Disparagement Cases | Insights
Skadden, Arps, Slate, Meagher & Flom LLP
The EC and the UK CMA are advancing investigations of a pharmaceutical company regarding a suspected anticompetitive disparagement campaign,...
1 month ago
CSL Vifor Offers Marketing Campaign to Reverse Alleged Anti-Competitive Practices
BioSpace
Published: Apr 22, 2024 By Tristan Manalac. Vifor Pharma_iStock, Denis Linine. Pictured: Vifor Pharma's office in Switzerland/iStock, Denis Linine.
1 month ago
The Commission's 'killer' pharma campaign: reason to complain?
Stibbe
The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it...
1 month ago
CSL Vifor and Travere Therapeutics announce sparsentan receives positive CHMP opinion for the treatment of IgA ...
PR Newswire
PRNewswire/ -- CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that the European Medicines Agency's (EMA) CHMP has...
3 months ago
CSL Vifor lays off 85 staffers in wake of $11.7B buyout
Fierce Pharma
A year after Vifor Pharma joined CSL under an M&A deal, the company has cut 85 employees based out of Vifor's Redwood City location in...
9 months ago
CMA investigates Vifor Pharma to safeguard essential anaemia treatment
GOV.UK
CMA investigates Vifor Pharma to safeguard essential anaemia treatment. The investigation will consider whether Vifor Pharma has been engaging...
4 months ago